NASDAQ: ACHVAchieve Life Sciences Inc Stock
$5.14-0.50 (-8.87%)
Updated Aug 16, 2022
ACHV Price
$5.14
Fair Value Price
$8.91
Market Cap
$49.76M
52 Week Low
$4.78
52 Week High
$10.09
P/E
-1.57x
P/B
3.78x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$31.88M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
1.58
Operating Cash Flow
-$29M
Beta
0.78
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ACHV Overview
Zen Score
–
Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ACHV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ACHV ($5.14) is undervalued by 42.29% relative to our estimate of its Fair Value price of $8.91 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ACHV ($5.14) is significantly undervalued by 42.29% relative to our estimate of its Fair Value price of $8.91 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ACHV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ACHV due diligence checks available for Premium users.
ACHV News
Valuation
ACHV fair value
Fair Value of ACHV stock based on Discounted Cash Flow (DCF)
Price
$5.14
Fair Value
$8.91
Undervalued by
42.29%
ACHV ($5.14) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ACHV ($5.14) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ACHV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
ACHV price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.57x
Industry
15.64x
Market
32.28x
ACHV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.78x
Industry
4.91x
ACHV is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ACHV's financial health
Profit margin
Revenue
$0.0
Net Income
-$10.5M
Profit Margin
0%
ACHV's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$34.0M
Liabilities
$20.8M
Debt to equity
1.58
ACHV's short-term assets ($31.15M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ACHV's short-term assets ($31.15M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ACHV's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ACHV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$8.3M
Investing
$0.0
Financing
$1.4M
ACHV's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ACHV vs Biotech Stocks
Achieve Life Sciences Stock FAQ
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.